Identifying the binding mode of a molecular scaffold

Area of Science:

• Computational Chemistry
• Structural Biology
• Drug Discovery

Background:

• Determining the binding mode of molecular scaffolds is crucial for structure-based drug design.
• Traditional docking methods often focus on individual ligands, which may not fully represent scaffold behavior.
• Protein kinase inhibitors (PKI) are a key class of drugs where scaffold binding is critical.

Purpose of the Study:

• To develop and validate a novel scaffold-based docking method for predicting the binding mode of molecular scaffolds.
• To demonstrate the advantages of docking a series of scaffold-sharing molecules over individual ligand docking.
• To establish a virtual screening tool for scaffold-based drug design processes.

Main Methods:

• Applied a scaffold-based docking approach using the FlexX software to eight different protein kinase inhibitor scaffolds.
• Determined the primary binding mode by analyzing the largest cluster of docked molecules sharing a common scaffold, using a 'nearest single neighbor' clustering method.
• Incorporated additional criteria to resolve cases with multiple significant binding modes.

Main Results:

• Successfully reconstructed most experimentally determined crystallographic binding modes for the studied scaffolds.
• Identified potential alternative binding modes not yet detected experimentally.
• Predicted the binding mode for a novel scaffold, showing high similarity to experimental data for a related scaffold.

Conclusions:

• The proposed scaffold-based docking method accurately predicts scaffold binding modes.
• This method offers advantages over single-ligand docking for understanding scaffold-protein interactions.
• The approach is suitable for virtual screening in scaffold-based drug design, potentially accelerating the discovery of new therapeutics.